GlassScriptPhysician profile
Wendy Summer Willis
NPI 1700188232
$2,400.42
in general payments reported to CMS, 2019-2025
19 companies · $350 in 2025
The $350 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $777 · 2020: $200 · 2021: $292 · 2022: $306 · 2023: $284 · 2024: $191 · 2025: $350.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $825.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $825.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $772.18 | 2019-2025 | Puraply, Via Matrix, Puraply Am |
| Paratek Pharmaceuticals, INC. | $331.45 | 2022-2025 | Nuzyra |
| Bioventus LLC | $152.91 | 2024-2025 | Exogen Ultrasound Bone Healing System |
| Misonix INC | $146.87 | 2019 | |
| Pfizer INC. | $132.67 | 2019 | |
| Horizon Therapeutics Plc | $121.93 | 2019 | |
| Smith+Nephew, INC. | $118.85 | 2019 | |
| Celularity INC. | $112.00 | 2019 | |
| Globus Medical, INC. | $96.69 | 2025 | Senza |
| Access Pro Medical, LLC | $80.82 | 2023 | Matriderm |
| Melinta Therapeutics, LLC | $79.89 | 2019-2020 | |
| Nevro Corp. | $47.20 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $45.90 | 2025 | |
| Axogen | $36.96 | 2019 | |
| Treace Medical Concepts, INC. | $34.43 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $33.70 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $22.69 | 2023 | Exparel |
| Stryker Corporation | $17.24 | 2021 | |
| Djo, LLC | $16.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wendy Willis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.